EP2146721
Aðferðir til að nota þvagtemprandi hormónamótlyf með antrasýklín lyfjameðferðarmiðlum til að draga úr hjartaskemmdum og/eða auka lífslíkur
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.5.2008EP published:
10.7.2013EP application number:
08755284.0
EP translation filed:
14.8.2013Grant published:
15.9.2013EPO information:
European Patent Register
Max expiry date:
11.5.2028Expiry date:
11.5.2016
Title:
METHODS FOR USING VASOPRESSIN ANTAGONISTS WITH ANTHRACYCLINE CHEMOTHERAPY AGENTS TO REDUCE CARDIOTOXICITY AND/OR IMPROVE SURVIVAL
Timeline
Today
12.5.2008EP application
10.7.2013EP Publication
14.8.2013Translation submitted
15.9.2013Registration published
11.5.2016Expires
Owner
Name:
Otsuka Pharmaceutical Co., Ltd.Address:
2-9, Kanda-Tsukasamachi Chiyoda-ku, 101-8535, Tokyo, JP
Inventor
Name:
LIU, YonggeAddress:
Rockville, Maryland, US
Name:
KAMBAYASHI, JunichiAddress:
Rockville, Maryland, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
938089 PDate:
15.5.2007Country:
US
Classification
Categories:
A01N 43/00, A61K 31/553, A61K 31/554, A61K 31/55, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.4.2014
Expires: 11.5.2015
Payer: Árnason Faktor
Number: 8
Paid: 9.4.2015
Expires: 11.5.2016
Payer: Árnason Faktor